These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32058)

  • 41. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on morphine-induced antinociception and brain mu, delta and kappa opiate receptors.
    Bhargava HN; Pandey RN; Matwyshyn GA
    Life Sci; 1983 May; 32(18):2096-101. PubMed ID: 6133201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Similar antagonism of morphine analgesia by MIF-1 and naloxone in Carassius auratus.
    Ehrensing RH; Michell GF; Kastin AJ
    Pharmacol Biochem Behav; 1982 Oct; 17(4):757-61. PubMed ID: 6129644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthetic melanocyte stimulating hormone release-inhibiting factor (MIF). Part III: effect of L-prolyl-N-methyl-D-leucyl-glycinamide and MIF on biogenic amine turnover.
    Pugsley TA; Lippmann W
    Arzneimittelforschung; 1977; 27(12):2293-6. PubMed ID: 23796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of naltrexone and prolyl-leucyl-glycinamide on drug-induced tremor and rigidity in the rat.
    Dickinson SL; Slater P; Longman DA
    Neuropharmacology; 1981 Aug; 20(8):757-62. PubMed ID: 6116207
    [No Abstract]   [Full Text] [Related]  

  • 45. Synthesis and dopamine receptor modulating activity of unsubstituted and substituted triproline analogues of L-prolyl-L-leucyl-glycinamide (PLG).
    Baures PW; Pradhan A; Ojala WH; Gleason WB; Mishra RK; Johnson RL
    Bioorg Med Chem Lett; 1999 Aug; 9(16):2349-52. PubMed ID: 10476867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of nitric oxide in catalepsy and hyperthermia in morphine-dependent rats.
    Afify EA; Daabees TT; Gabra BH; Abou Zeit-Har MS
    Pharmacol Res; 2001 Dec; 44(6):533-9. PubMed ID: 11735362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Memory enhancement induced in chicks by L-prolyl-L-leucyl-glycinamide.
    Davis JL; Pico RM; Cherkin A
    Pharmacol Biochem Behav; 1982 Nov; 17(5):893-6. PubMed ID: 6129646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prolyl-leucyl-glycinamide reduces aggression and blocks defeat-induced opioid analgesia in mice.
    Teskey GC; Kavaliers M
    Peptides; 1985; 6(2):165-7. PubMed ID: 2863808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta-analogs of PLG (L-prolyl-L-leucyl-glycinamide): ex-chiral pool syntheses and dopamine D2 receptor modulating effects.
    Thomas C; Ohnmacht U; Niger M; Gmeiner P
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2885-90. PubMed ID: 9873642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C-terminal fragments of oxytocin (prolyl-leucyl-glycinamide and Z-prolyl-D-leucine) attenuate the development of tolerance to ethanol.
    Szabó G; Kovács GL; Székeli S; Baláspiri L; Telegdy G
    Acta Physiol Hung; 1987; 69(1):115-22. PubMed ID: 2884803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth hormone releasing activity of small peptides: effect of pyroglutamyl-seryl-glycinamide and thyrotropin releasing hormone on rat pituitaries.
    Miasiro N; Pupo AA; Paiva AC
    An Acad Bras Cienc; 1978 Dec; 50(4):581-5. PubMed ID: 107838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of the tripeptides TRH, MIF and MAF on the cerebral dopaminergic system.
    Klusha B; Georgiev V; Petkov V; Markovska V
    Acta Physiol Pharmacol Bulg; 1983; 9(2):14-9. PubMed ID: 6140814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of TRH on the catalepsy induced by various neuroleptics].
    Alamo C; Vallejo M; Cuenca E
    Arch Farmacol Toxicol; 1982 Dec; 8(3):151-6. PubMed ID: 6134498
    [No Abstract]   [Full Text] [Related]  

  • 54. Systemically administered prolyl-leucyl-glycinamide fails to alter dopaminergic neuronal activity in the rat brain.
    Alper RH; Moore KE
    J Pharm Pharmacol; 1981 Apr; 33(4):259-61. PubMed ID: 6115917
    [No Abstract]   [Full Text] [Related]  

  • 55. CNS and pituitary effects of hypothalamic peptides and MSH.
    Kastin AJ; Miller LH; Sandman CA; Schally AV; Plotnikoff NP
    Essays Neurochem Neuropharmacol; 1977; 1():139-76. PubMed ID: 30623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of somatostatin and of prolyl-leucyl-glycinamide (MIF) on ACTH release in dispersed pituitary cells.
    Voight KH; Fehm HL; Lang RE; Walter R
    Life Sci; 1977 Sep; 21(5):739-45. PubMed ID: 20545
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of thyrotropin-releasing hormone with melanocyte-stimulating-hormone-release-inhibiting factor as pentobarbital antagonists in monkeys.
    Crowley TJ; Hydinger M
    Psychopharmacology (Berl); 1977 Jul; 53(2):205-6. PubMed ID: 19803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of desglycinamide(9)-lysine(8)-vasopressin and prolyl-leucyl-glycinamide on oral ethanol intake in the rat.
    Mucha RF; Kalant H
    Pharmacol Biochem Behav; 1979 Feb; 10(2):229-34. PubMed ID: 36634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stimulant effect of thyrotropin-releasing hormone and its analog, RGH 2202, on the diaphragm respiratory activity, and their antagonism with morphine: possible involvement of the N-methyl-D-aspartate receptors.
    Kharkevich DA; Chizh BA; Kasparov SA
    Brain Res; 1991 Jun; 551(1-2):110-5. PubMed ID: 1833029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Failure of prolyl-leucyl-glycinamide to alter analgesia measured by the Takemori test in morphine-pretreated rats.
    Mucha RF; Kalant H
    J Pharm Pharmacol; 1979 Aug; 31(8):572-3. PubMed ID: 40008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.